Table 2.
Comparison of MoCA scores, serum thiamin, folic acid and homocysteine in the control and treatment group at baseline, 48 weeks and 96 weeks of follow-up.
Treatment group (n = 22) | Control group (n = 16) | p Value | |
---|---|---|---|
MoCA | |||
Baseline | 21.95 ± 3.81 | 20.69 ± 3.40 | 0.297 |
48 weeks | 25.68 ± 2.40 | 20.00 ± 3.95 | <0.001 |
96 weeks | 25.68 ± 1.96 | 19.63 ± 3.58 | <0.001 |
Comparison between 96 weeks and baseline, p value | <0.001 | 0.657 | |
Treatment difference over time, p value | <0.001 | 0.304 | |
Thiamin (nmol/L) | |||
Baseline | 53.63 ± 7.33 | 51.98 ± 10.13 | 0.563 |
48 weeks | 57.79 ± 6.09 | 54.90 ± 6.28 | 0.163 |
96 weeks | 57.60 ± 5.86 | 52.87 ± 4.45 | 0.011 |
Comparison between 96 weeks and baseline, p value | 0.168 | 1.000 | |
Treatment difference over time, p value | 0.063 | 0.499 | |
Folic acid (ng/mL) | |||
Baseline | 7.88 ± 2.18 | 8.39 ± 2.63 | 0.519 |
48 weeks | 21.94 ± 4.85 | 8.09 ± 4.62 | <0.001 |
96 weeks | 18.35 ± 7.94 | 7.3 ± 4.83 | <0.001 |
Comparison between 96 weeks and baseline, p value | <0.001 | 0.870 | |
Treatment difference over time, p value | <0.001 | 0.719 | |
Homocysteine (μmol/L) | |||
Baseline | 43.55 ± 21.81 | 48.72 ± 27.43 | 0.522 |
48 weeks | 33.64 ± 13.04 | 41.36 ± 13.34 | 0.083 |
96 weeks | 32.58 ± 13.42 | 45.69 ± 18.54 | 0.016 |
Comparison between 96 weeks and baseline, p value | 0.111 | 1.000 | |
Treatment difference over time, p value | 0.063 | 0.594 |